Fluorine in PDB 7to6: Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2]
Protein crystallography data
The structure of Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2], PDB code: 7to6
was solved by
Y.-F.Wang,
J.Agniswamy,
A.K.Ghosh,
I.T.Weber,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
50.00 /
1.21
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
58.732,
86.238,
45.961,
90,
90,
90
|
R / Rfree (%)
|
n/a /
n/a
|
Other elements in 7to6:
The structure of Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2] also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2]
(pdb code 7to6). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2], PDB code: 7to6:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 7to6
Go back to
Fluorine Binding Sites List in 7to6
Fluorine binding site 1 out
of 4 in the Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2]
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2] within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:18.0
occ:0.55
|
F61
|
B:G77201
|
0.0
|
18.0
|
0.6
|
C34
|
B:G77201
|
1.4
|
13.4
|
0.6
|
C35
|
B:G77201
|
2.4
|
15.1
|
0.6
|
C33
|
B:G77201
|
2.4
|
12.3
|
0.6
|
C15
|
B:G77201
|
3.0
|
12.7
|
0.5
|
NH2
|
B:ARG8
|
3.2
|
35.4
|
1.0
|
NH1
|
B:ARG8
|
3.4
|
41.2
|
1.0
|
O
|
B:HOH345
|
3.5
|
23.3
|
0.5
|
O
|
A:HOH655
|
3.5
|
14.1
|
0.5
|
C25
|
B:G77201
|
3.5
|
15.3
|
0.6
|
C36
|
B:G77201
|
3.6
|
13.8
|
0.6
|
C38
|
B:G77201
|
3.7
|
10.5
|
0.6
|
CZ
|
B:ARG8
|
3.7
|
34.4
|
1.0
|
O
|
A:HOH650
|
3.8
|
26.1
|
1.0
|
O
|
A:HOH613
|
3.9
|
28.4
|
1.0
|
O
|
B:HOH364
|
3.9
|
35.2
|
0.5
|
C12
|
B:G77201
|
4.0
|
10.9
|
0.5
|
C13
|
B:G77201
|
4.1
|
9.8
|
0.5
|
C37
|
B:G77201
|
4.2
|
12.3
|
0.6
|
CG1
|
B:VAL82
|
4.2
|
29.4
|
1.0
|
C41
|
B:G77201
|
4.3
|
13.5
|
0.6
|
O
|
A:GLY27
|
4.6
|
12.2
|
1.0
|
C24
|
B:G77201
|
4.6
|
13.5
|
0.6
|
O23
|
B:G77201
|
4.7
|
16.0
|
0.6
|
CB
|
B:VAL82
|
4.7
|
24.1
|
1.0
|
F62
|
B:G77201
|
4.8
|
14.5
|
0.6
|
O
|
A:GLY48
|
4.8
|
13.2
|
1.0
|
NE
|
B:ARG8
|
4.8
|
29.9
|
1.0
|
CD2
|
B:LEU23
|
4.9
|
16.3
|
1.0
|
C4
|
B:G77201
|
4.9
|
10.2
|
0.5
|
C21
|
B:G77201
|
5.0
|
12.8
|
0.6
|
C14
|
B:G77201
|
5.0
|
11.8
|
0.5
|
C32
|
B:G77201
|
5.0
|
10.5
|
0.6
|
|
Fluorine binding site 2 out
of 4 in 7to6
Go back to
Fluorine Binding Sites List in 7to6
Fluorine binding site 2 out
of 4 in the Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2]
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2] within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:15.6
occ:0.45
|
F61
|
B:G77201
|
0.0
|
15.6
|
0.5
|
C34
|
B:G77201
|
1.3
|
12.2
|
0.5
|
O
|
B:HOH337
|
2.3
|
26.3
|
0.6
|
C35
|
B:G77201
|
2.3
|
13.8
|
0.5
|
C33
|
B:G77201
|
2.4
|
12.0
|
0.5
|
C15
|
B:G77201
|
2.8
|
14.3
|
0.6
|
NH2
|
A:ARG8
|
3.3
|
45.1
|
1.0
|
CG2
|
A:VAL82
|
3.5
|
15.7
|
0.6
|
NH1
|
A:ARG8
|
3.5
|
29.2
|
1.0
|
C25
|
B:G77201
|
3.6
|
15.8
|
0.5
|
C36
|
B:G77201
|
3.6
|
11.9
|
0.5
|
C38
|
B:G77201
|
3.6
|
9.3
|
0.5
|
CZ
|
A:ARG8
|
3.7
|
33.0
|
1.0
|
O
|
A:HOH678
|
3.8
|
33.8
|
0.5
|
O
|
B:HOH330
|
3.8
|
20.8
|
0.6
|
O
|
B:HOH334
|
3.9
|
19.2
|
1.0
|
CG1
|
A:VAL82
|
4.0
|
19.2
|
0.5
|
C13
|
B:G77201
|
4.0
|
12.4
|
0.6
|
C12
|
B:G77201
|
4.0
|
11.9
|
0.6
|
C37
|
B:G77201
|
4.1
|
10.7
|
0.5
|
CB
|
A:VAL82
|
4.4
|
16.1
|
0.6
|
C41
|
B:G77201
|
4.4
|
15.0
|
0.5
|
C24
|
B:G77201
|
4.6
|
14.2
|
0.5
|
CB
|
A:VAL82
|
4.6
|
17.1
|
0.5
|
O
|
B:GLY27
|
4.7
|
13.9
|
1.0
|
CG1
|
A:VAL82
|
4.7
|
18.9
|
0.6
|
F62
|
B:G77201
|
4.7
|
14.4
|
0.5
|
O
|
B:GLY48
|
4.8
|
15.5
|
1.0
|
NE
|
A:ARG8
|
4.8
|
27.1
|
1.0
|
O23
|
B:G77201
|
4.8
|
13.3
|
0.5
|
CD2
|
A:LEU23
|
4.8
|
19.3
|
1.0
|
C14
|
B:G77201
|
4.9
|
14.1
|
0.6
|
C32
|
B:G77201
|
4.9
|
10.0
|
0.5
|
C21
|
B:G77201
|
4.9
|
10.8
|
0.5
|
|
Fluorine binding site 3 out
of 4 in 7to6
Go back to
Fluorine Binding Sites List in 7to6
Fluorine binding site 3 out
of 4 in the Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2]
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2] within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:14.5
occ:0.55
|
F62
|
B:G77201
|
0.0
|
14.5
|
0.6
|
C36
|
B:G77201
|
1.4
|
13.8
|
0.6
|
CG
|
B:PRO81
|
2.1
|
20.1
|
0.5
|
C37
|
B:G77201
|
2.4
|
12.3
|
0.6
|
C35
|
B:G77201
|
2.4
|
15.1
|
0.6
|
C
|
A:GLY49
|
2.8
|
15.2
|
1.0
|
N
|
A:ILE50
|
2.9
|
14.2
|
0.6
|
N
|
A:ILE50
|
3.0
|
13.8
|
0.5
|
CD
|
B:PRO81
|
3.0
|
22.2
|
0.5
|
CD
|
B:PRO81
|
3.1
|
21.3
|
0.6
|
CG
|
B:PRO81
|
3.1
|
19.8
|
0.6
|
CA
|
A:GLY49
|
3.1
|
22.9
|
1.0
|
C14
|
B:G77201
|
3.3
|
11.8
|
0.5
|
O
|
A:GLY49
|
3.3
|
14.4
|
1.0
|
CB
|
B:PRO81
|
3.4
|
19.7
|
0.5
|
CA
|
A:ILE50
|
3.4
|
13.3
|
0.5
|
CB
|
B:PRO81
|
3.5
|
18.4
|
0.6
|
C38
|
B:G77201
|
3.6
|
10.5
|
0.6
|
C34
|
B:G77201
|
3.7
|
13.4
|
0.6
|
CA
|
A:ILE50
|
3.7
|
13.2
|
0.6
|
C15
|
B:G77201
|
4.1
|
12.7
|
0.5
|
O
|
A:HOH654
|
4.1
|
25.5
|
0.6
|
N
|
A:GLY49
|
4.1
|
18.7
|
1.0
|
C33
|
B:G77201
|
4.1
|
12.3
|
0.6
|
CG1
|
A:ILE50
|
4.1
|
20.5
|
1.0
|
C13
|
B:G77201
|
4.2
|
9.8
|
0.5
|
N
|
B:PRO81
|
4.2
|
17.8
|
1.0
|
CB
|
A:ILE50
|
4.3
|
15.2
|
1.0
|
CA
|
B:PRO81
|
4.4
|
16.8
|
0.5
|
O
|
A:GLY48
|
4.4
|
13.2
|
1.0
|
CA
|
B:PRO81
|
4.5
|
16.9
|
0.6
|
CG1
|
B:VAL82
|
4.5
|
29.4
|
1.0
|
O10
|
B:G77201
|
4.6
|
11.6
|
0.5
|
C12
|
B:G77201
|
4.6
|
10.9
|
0.5
|
C
|
A:ILE50
|
4.6
|
11.5
|
0.5
|
C
|
A:GLY48
|
4.7
|
13.3
|
1.0
|
O
|
B:HOH303
|
4.7
|
15.9
|
1.0
|
OG1
|
B:THR80
|
4.7
|
17.2
|
1.0
|
F61
|
B:G77201
|
4.8
|
18.0
|
0.6
|
N
|
B:VAL82
|
4.8
|
17.1
|
1.0
|
C32
|
B:G77201
|
4.9
|
10.5
|
0.6
|
O9
|
B:G77201
|
4.9
|
11.5
|
0.6
|
O22
|
B:G77201
|
4.9
|
14.2
|
0.6
|
C
|
B:PRO81
|
4.9
|
18.5
|
1.0
|
C
|
A:ILE50
|
5.0
|
13.0
|
0.6
|
|
Fluorine binding site 4 out
of 4 in 7to6
Go back to
Fluorine Binding Sites List in 7to6
Fluorine binding site 4 out
of 4 in the Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2]
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Hiv-1 Wild Type Protease with Grl-01717A, with C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2- Ligand [Diastereomer 2] within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:14.4
occ:0.45
|
F62
|
B:G77201
|
0.0
|
14.4
|
0.5
|
C36
|
B:G77201
|
1.4
|
11.9
|
0.5
|
C37
|
B:G77201
|
2.4
|
10.7
|
0.5
|
C35
|
B:G77201
|
2.4
|
13.8
|
0.5
|
CG
|
A:PRO81
|
2.5
|
18.5
|
0.6
|
C
|
B:GLY49
|
2.8
|
16.1
|
1.0
|
N
|
B:ILE50
|
2.8
|
15.0
|
0.5
|
CD
|
A:PRO81
|
2.9
|
19.0
|
0.6
|
N
|
B:ILE50
|
2.9
|
14.7
|
0.6
|
CD
|
A:PRO81
|
3.0
|
18.6
|
0.5
|
CG
|
A:PRO81
|
3.0
|
19.5
|
0.5
|
O
|
B:HOH337
|
3.1
|
26.3
|
0.6
|
CA
|
B:GLY49
|
3.2
|
23.5
|
1.0
|
O
|
B:GLY49
|
3.2
|
14.9
|
1.0
|
CA
|
B:ILE50
|
3.3
|
14.3
|
0.6
|
C14
|
B:G77201
|
3.4
|
14.1
|
0.6
|
CA
|
B:ILE50
|
3.5
|
13.3
|
0.5
|
CB
|
A:PRO81
|
3.5
|
17.8
|
0.5
|
C38
|
B:G77201
|
3.6
|
9.3
|
0.5
|
C34
|
B:G77201
|
3.6
|
12.2
|
0.5
|
CB
|
A:PRO81
|
4.0
|
19.0
|
0.6
|
CG1
|
B:ILE50
|
4.0
|
20.4
|
1.0
|
C33
|
B:G77201
|
4.1
|
12.0
|
0.5
|
CB
|
B:ILE50
|
4.1
|
14.2
|
1.0
|
C15
|
B:G77201
|
4.2
|
14.3
|
0.6
|
N
|
A:PRO81
|
4.2
|
15.6
|
1.0
|
N
|
B:GLY49
|
4.2
|
19.4
|
1.0
|
C13
|
B:G77201
|
4.3
|
12.4
|
0.6
|
CG1
|
A:VAL82
|
4.4
|
19.2
|
0.5
|
C
|
B:ILE50
|
4.5
|
14.3
|
0.6
|
CA
|
A:PRO81
|
4.5
|
16.7
|
0.5
|
OG1
|
A:THR80
|
4.5
|
14.6
|
1.0
|
O
|
B:GLY48
|
4.5
|
15.5
|
1.0
|
O
|
B:HOH303
|
4.6
|
15.9
|
1.0
|
O10
|
B:G77201
|
4.6
|
11.5
|
0.6
|
O
|
B:HOH317
|
4.6
|
24.2
|
1.0
|
C12
|
B:G77201
|
4.7
|
11.9
|
0.6
|
CA
|
A:PRO81
|
4.7
|
17.4
|
0.6
|
C
|
B:GLY48
|
4.7
|
14.5
|
1.0
|
F61
|
B:G77201
|
4.7
|
15.6
|
0.5
|
O22
|
B:G77201
|
4.7
|
14.7
|
0.5
|
N
|
A:VAL82
|
4.8
|
16.3
|
1.0
|
C
|
B:ILE50
|
4.9
|
13.1
|
0.5
|
O9
|
B:G77201
|
4.9
|
9.6
|
0.5
|
C32
|
B:G77201
|
4.9
|
10.0
|
0.5
|
CG2
|
A:VAL82
|
5.0
|
15.7
|
0.6
|
O
|
B:ILE50
|
5.0
|
17.7
|
0.6
|
CD1
|
B:ILE50
|
5.0
|
22.1
|
1.0
|
|
Reference:
A.K.Ghosh,
S.Kovela,
A.Sharma,
D.Shahabi,
A.K.Ghosh,
D.R.Hopkins,
M.Yadav,
M.E.Johnson,
J.Agniswamy,
Y.F.Wang,
S.I.Hattori,
N.Higashi-Kuwata,
M.Aoki,
M.Amano,
I.T.Weber,
H.Mitsuya.
Design, Synthesis and X-Ray Structural Studies of Potent Hiv-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-Furofuran Derivatives As P2 Ligands. Chemmedchem V. 17 00058 2022.
ISSN: ESSN 1860-7187
PubMed: 35170223
DOI: 10.1002/CMDC.202200058
Page generated: Fri Aug 2 13:30:12 2024
|